QT
JANX icon

Quantbot Technologies’s Janux Therapeutics JANX Stock Holding History

Quantbot Technologies’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.4K Buy
5,497
+5,267
+2,290% +$76.3K ﹤0.01% 1510
2026
Q1 		$3.2K Sell
230
-15,118
-99% -$207K ﹤0.01% 1590
2025
Q4 		$212K Buy
+15,348
New +$361K 0.01% 1222
2025
Q1 		– Sell
-1
Closed -$54 – 1674
2024
Q4 		$54 Sell
1
-65
-98% -$3.44K ﹤0.01% 1422
2024
Q3 		$3K Buy
+66
New +$2.87K ﹤0.01% 1378

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Quantbot Technologies's JANX Position: Q2 2026 in Review

Quantbot Technologies increased its Janux Therapeutics (JANX) stake by 2,290% in Q2 2026, buying an estimated $76.3K and bringing the position to 5,497 shares worth $84.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Quantbot Technologies first reported a position in JANX in Q3 2024 and has held it in 5 quarters since. The position peaked at $212K in Q4 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Quantbot Technologies held 5,497 shares of Janux Therapeutics worth $84.4K as of Q2 2026.
  • Quantbot Technologies bought 5,267 Janux Therapeutics shares in Q2 2026, an estimated $76.3K.
  • Janux Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1510 holding.
  • Quantbot Technologies first reported a position in Janux Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • Quantbot Technologies's Janux Therapeutics position peaked at $212K in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.